| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_577821cf81fda3e1088e6ed08bcd136b |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y301-21001
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-465
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-46 |
| filingDate |
2001-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ddb1e55c12ad462a6a55e5a167977cd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e3fce9ac7b2f52774490ed4fb07dd96
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c5498fc0153e395a6d05c532dd385c7 |
| publicationDate |
2002-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1249244-A1 |
| titleOfInvention |
Therapeutic compositions for the treatment of a disease modulated by the G-actin / F-actin equilibrium, especially a respiratory tract disease |
| abstract |
The equilibrium between G actin and F actin is shifted towards the F actinnconfirmation with compounds such as the ionic form of magnesium ornpotassium. The higher amount of F actin decreases the inhibition of nucleasesnsuch as DNAsel by monomeric G actin. The increased performance of thennuclease results in better treatment of patients suffering from cystic fibrosis ornother diseases associated with viscous mucus. |
| priorityDate |
2001-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |